It's not a Brexit problem, Sanofi says of epilepsy drug shortages

Sanofi has restarted production at a plant where manufacturing had to be halted to fix pollution issues. The interruption created spot shortages of seizure drugs Epilim and Depakote in some markets, but Sanofi has assured patients it has nothing to do with the impending divorce of the U.K. and the European Union.